Early passaged bovine pulmonary artery endothelial cells exposed to 0.1-2.0 ng/ml transforming growth factor-beta 1 (TGF-fi1) showed concentration-dependent growth inhibition, as assessed by 13Hlthymidine labeling and cell counts, over a 96-h interval. Most of the inhibition of [3Hithymidine labeling measured at 96 h persisted when the medium was replaced with TGF-fil-free medium after 24 h, but the inhibition of labeling was prevented by the presence of anti-TGF-ftl antibody in the replacement medium. Additions of 2 mM cysteine, 1 mM cystine, or 2 mM N-acetylcysteine at the time ofthe initial addition of TGF-fl1 blocked the inhibitory effect of TGF-j81 on 13H1-thymidine labeling when this was assessed after 72-96 h, but not at earlier times. Prevention of the inhibitory effect on cellular proliferation produced by cysteine, cystine and N-acetylcysteine was associated with elevation of cellular glutathione that was present at 48-96 h. There was no evidence for direct inactivation of TGF-ft1 by the thiol-amino acids. Conditioned medium from TGF-tl-treated endothelial cells inhibited proliferation of mink lung carcinoma (CCL64) cells, supporting a previously reported concept of autocrine production of TGF-ftI by the endothelial cells. The inhibitory action of the conditioned medium was partially prevented when 1 mM cysteine was added during conditioning. Thus, TGF-,BI treatment ofendothelial cells appears to set offautocrine production by these cells of TGF-,81 that perpetuates the inhibition of cellular proliferation. Replenishment of cellular glutathione with thiol-amino acids counteracts the growth-inhibitory effect of TGF-,S1 through a currently undefined mechanism. (J. Clin. Invest.
Introduction
Transforming growth factor-l1 (TGF-#31 )' is a 25-kD dimeric protein that belongs to a family of five closely related peptides. 1 . Abbreviations used in this paper: TdR, thymidine; TGF, transforming growth factor.
It has numerous effects on growth and differentiation of many cell types ( 1, 2) . Initially TGF-#'s were found to stimulate the anchorage independent growth offibroblasts in soft agar. Later studies revealed that they also inhibit the proliferation of a number of other cells in culture, including endothelial cells (3) (4) (5) . TGF-,3's also stimulate collagen synthesis (6) (7) (8) , suppress T and B lymphocyte activity (9, 10) , promote chemotaxis for monocytes and macrophages ( 11) , and act as mitogens for osteoblasts ( 12) . Recently TGF-#3l was shown to suppress human immunodeficiency virus replication in cells ofthe monocyte/macrophage lineage ( 13) . In general, mammalian cells possess receptors for TGF-#'s, and the peptides are thought to regulate cell function via paracrine and autocrine systems ( 1, 2) .
Experiments performed in this laboratory have shown that TGF-Il effects on endothelial cells are°2 dependent and blocked by antioxidants. We have referred to this as a "pro-oxidant" effect of TGF-,tl (14) . Furthermore, TGF-j31 lowers cellular glutathione over the same time period as it produces the pro-oxidant effect ( 15 ) . To further investigate the modulation of the TGF-# I effect on endothelial cells, we have carried out experiments that evaluate its reversibility. In this report we show that TGF-#lI produces both early (within 24 h) and protracted (several days) effects on endothelial cells manifested by inhibition of radioactive thymidine (TdR) uptake and cellular proliferation. When cysteine, cystine, or N-acetylcysteine is applied with TGF-,B1, the late effect on TdR uptake, but not the early one, is significantly attenuated. The attenuation ofinhibition of TdR uptake with these agents is associated with elevation oftotal cellular glutathione. Studies utilizing anti-TGF-, I antibody in endothelial cell cultures and conditioned medium of endothelial cells on mink lung carcinoma cells (CCL64) support a concept that TGF-,61 up-regulates its own production in an autocrine manner and that this is likely to play a role in the prolonged growth inhibitory effect of TGF-,B1. Furthermore, cellular glutathione availability appears to regulate the growth inhibitory process produced by TGF-#l, and we propose that this effect may occur through regulation of the autocrine production of TGF-fll.
Methods
Reagents. Porcine platelet TGF-fl and chicken anti-TGF-,ll antibody were obtained from R&D Systems, Minneapolis, MN. The TGF-/11 was reconstituted in 4 mM HCO according to instructions of the supplier.
Cell culture. Third-to sixth-passaged bovine pulmonary artery endothelial cells were procured as previously described ( 16 Measurement of cellular glutathione. Culture dishes were rinsed three times with warm PBS and incubated for 3 min with 1.0 ml trypsin-EDTA at 37°C. The cells were rapidly suspended by pipetting and chilled immediately on ice. An aliquot of0.2 ml ofthe cellular suspension was removed and diluted for counting in a model ZM Coulter counter. The remaining 0.8 ml of suspension was treated with 0.1 ml 10% perchloric acid to precipitate cell proteins, sonicated, and centrifuged at 2,600 g for 20 min. The supernatant obtained from centrifugation was immediately frozen at -20°C for subsequent assays ofcellular glutathione. To assay for total cellular glutathione, the previously frozen perchloric acid-treated supernatants were thawed and sonicated. The pH was adjusted to 7.0 with 0.3 M potassium hydroxide-3-(Nmorpholino) propanesulfonic acid (pH 13.6) to neutralize the perchloric acid, and the sonicate was centrifuged and assayed for total glutathione by the Tietze method as described by Akerboom and Sies ( 19) .
Briefly, the sum ofthe oxidized (GSSG) and reduced (GSH) forms ofglutathione were determined using a kinetic assay in which GSH or GSSG and glutathione reductase reduce 5,5'-dithiobis (2-nitrobenzoic acid) to form 5-thio-2-nitrobenzoate. The formation of 5-thio-2-nitrobenzoate was assessed spectrophotometrically at 412 nm. Each assay was individually calibrated with standard glutathione and the concentration ofeach sample was adjusted by dilution to ensure that the reaction rate was on the linear portion of the standard curve.
Inhibition ofmink lung carcinoma cell proliferation by endothelial cell conditioned medium. Endothelial cells were treated with 0.1-2.0 ng/ml TGF-,B1 for 24 h. After this, the media containing TGF-I1 were removed and the culture dishes were rinsed once with TGF-# l-free medium. The cells were then reincubated in TGF-/Il-free medium for an additional 96 h. In some ofthe cultures, 1 mM cysteine was present during the final 96-h incubation period. Conditioned medium thus obtained was applied directly to mink lung carcinoma line CCL64 obtained from the American Type Culture Collection, Rockville, MD, and cell proliferation was measured 48 h later by determination ofcell number by Coulter counter analysis.
Experimental procedures. All experiments were done at least in duplicate and representative experiments are shown. For some experiments multiple samples (n = 4) were tested and standard deviations were calculated.
Results
Effect of TGF-fl1 on [HI] TdR uptake by bovine pulmonary artery endothelial cells. We previously found that TGF-11 at concentrations of0.1-2.0 ng/ml inhibits uptake ofradioactive thymidine by bovine pulmonary artery endothelial cells when it is measured at 48 h of incubation ( 14) . We present more detailed observations of this effect in Fig (Fig. 2, right) . Removal of TGF-f 1-containing medium at 2 h produced a similar inhibitory effect on cell proliferation as removal at 6 or 24 h when cell counts were done at 120 h (Fig. 3) Fig. 4, a out in the presence or absence of2 mM cysteine or its analogue, 2 mM N-acetylcysteine, the rates of[3H ] TdR uptake were similarly suppressed for the first 72 h (data obtained at 24 and 48 h also showing no effect of the thiol-amino acid are not shown). However, at 96 h the rates of [3H] TdR uptake were higher in cultures treated with combined TGF-# I and cysteine or N-acetylcysteine as compared with TGF-131 alone (Fig. 4, c and d) ,
indicating an attenuation of the TGF-#3I effect after -72 h of contact with the thiol-amino acid.
The effect of TGF-$l was somewhat reduced by removing it from culture media at 24 h after initiation of experiments (Fig. 2) , and we wished to determine whether the recovery process might be augmented by the addition ofcysteine. These experiments were carried out similarly to those shown in Fig. 2 (right), except initial media were replaced with media containing 2 mM cysteine after 24 h in some samples, and prolifera- In aerobic solution cysteine is largely converted to cystine within 24 h (20). Because our experiments were carried out for a prolonged time interval, we determined whether cystine might also attenuate the TGF-#3I effects. Cultures were treated with TGF-f31 in the presence or absence of cystine (0.2-1.0 mM) and the rate of [3H]TdR uptake was determined at 120 h of incubation. As shown in Fig. 6 , cystine also attenuated the effect of TGF-f 1 on the rate of [3H] TdR uptake by the endothelial cells.
In that TGF-# I is a homodimeric protein joined by -S-Sbridge(s), we considered the possibility that the effects ofTGFf31 may be attentuated by cysteine through direct inactivation ofTGF-f31 through the reduction of-S-S-bridges in the biologically active molecule. However, preincubation of TGF-$l at concentrations up to 1.0 ng/ml with cysteine at concentrations up to 2.0 mM for 2 h failed to alter the inhibitory effect of TGF-3l1 on [3H]TdR uptake by endothelial cells at 48 h of incubation (Fig. 7) . Longer preincubation (up to 48 h) also failed to influence the growth inhibitory effect of TGF-#31 (data not shown).
Influence ofcysteine, N-acetylcysteine, and cystine on cellular glutathione in the presence of TGF-f31. Endothelial cells were seeded at low density and grown as described in Methods.
Cells were then exposed to 1 ng/ml TGF-#3I with and without cysteine (2 mM), cystine ( 1 mM), or N-acetylcysteine (2 mM) in 4 ml of medium for 96 h and cell counts and glutathione levels were measured. TGF-# 1 alone reduced both cell counts and cellular glutathione (Fig. 8) . The addition ofcysteine, cystine, and N-acetylcysteine to the medium of the TGF-#3I-exposed cells reversed total cellular glutathione level and cell counts toward or to control levels.
Growth-inhibitory effects ofconditioned media from TGF-$I-treated endothelial cells on mink lung carcinoma cells.
CCL64 cells showed pronounced growth inhibition in the presence of 0.1-1.0 ng/ml TGF-,13. We utilized this cell line to investigate the possible autocrine production of TGF-fl1 by endothelial cells treated with TGF-,B1 for 24 h. As shown in a representative experiment in Table I , conditioned medium from cell cultures pretreated with TGF-# I produced inhibition of CCL64 cell proliferation. The presence of cysteine during the conditioning period greatly reduced the inhibition of CCL64 growth by the conditioned medium.
Discussion
Although TGF-B I has previously been demonstrated to inhibit the proliferation of endothelial cells in culture (4), details regarding the mechanism of inhibition and its reversibility have not been adequately explored. We have proposed that inhibition ofproliferation by TGF-,B1 may be produced by a "pro-oxidant" effect of this cytokine ( 14) and that the pro-oxidant effect may be potentiated by the lowering of cellular glutathione by TGF-lI ( 15 ). TGF-81 (ng/ml) even when it was removed from the medium after 24 h. Furthermore, removal at 2 h produced the same inhibitory effect as removal at 24 h, suggesting that TGF-Il rapidly binds to its receptor and sets into motion a progressive and irreversible inhibition of cellular proliferation. The rapid binding of TGF-,I to its receptor is consistent with other reports (21 ) . Experiments showing that (a) an antibody to TGF-3l reverses the inhibitory effect of TGF-# 1 when added 24 h after the initial introduction ofTGF-#I concurrently with removal of TGF-f3l from the medium, and (b) conditioned medium from TGF-, 1-treated cells contains an antiproliferative factor for mink lung carcinoma cells suggest that autocrine production of TGF-31 occurs, thus perpetuating inhibition of cellular proliferation. In this regard, our interpretations are similar to those forwarded by other authors who have observed stimulation of cell growth by anti-TGF-# l antibody and attributed this effect to autocrine production ofTGF-,81 (22, 23) . It is possible that the antibody is influencing intracellular TGF-#I that is still available in the cell for liganding after 24 h; however, we think this mechanism is less likely, particularly in view of our data with conditioned medium and the current understanding of TGF-#3I receptor interaction. It has been shown that bound TGF-(31 is internalized and degraded by lysosomal enzymes within 4 h at 370C (21) .
Inhibition of proliferation of the mink lung carcinoma cell has been used conventionally as a bioassay for the measurement of TGF-BIl ( 1, 2). In the current experiments, we have made use of this assay to determine if an antiproliferative substance might be released into the media of TGF-fl1-treated endothelial cells. TGF-Il treatment does, indeed, stimulate the production of such an inhibitory substance, and, consistent with a mechanism of regulation of its production by thiolamino acid availability, exogenous cysteine attentuates the inhibition. Although we cannot be sure that the inhibitory substance is TGF-lI, our experiments with antibody to TGF-#3I support this contention.
Cysteine, cystine, and N-acetylcysteine all attentuated both the TGF-#l antiproliferative and glutathione-depleting effects on endothelial cells, but this was not observed for the first 48-72 h of incubation. Thus, the blocking effect ofthese agents on inhibition of cellular proliferation is delayed. point of our measurement. Maintenance or elevation of cellular glutathione by these thiol-amino acids or the N-acetylcysteine analogue might be anticipated since they provide substrate for intracellular synthesis ofglutathione (24) . Cysteine is internalized by sodium-dependent pathways (A or ASC carrier system) (25, 26) and cystine by the sodium-independent Xsystem. N-acetylcysteine probably forms cysteine through a mixed disulfide reaction and cysteine is subsequently internalized through the A or ASC carrier system (27) . Since our experiments were prolonged, any cysteine initially added to medium is probably totally oxidized to cystine within 24 h (28). Consideration was given to the possibility that the thiol amino acids might inactivate TGF-#lI directly, perhaps by the formation of mixed disulfides or the oxidation of thiol groups on the molecule. This is unlikely because (a) the disulfide reversal ofthe TGF-#l effect observed in these experiments. In summary, our results are the first to demonstrate that thiolamino acid availability and production by mammalian cells may significantly alter the cellular response to the cytokine TGF-#l. The thiol amino acids may thus modulate the effect of TGF-#l on certain cell types by down-regulating autocrine production of TGF-j31.
